Health-Related Quality of Life of Pembrolizumab for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma in KEYNOTE-629

被引:0
|
作者
Hughes, B. G. M. [1 ,2 ]
Mendoza Gonzalez, R. [3 ]
Basset-Seguin, N. [4 ]
Vornicova, O. [5 ]
Schachter, J. [6 ]
Joshi, A. [7 ]
Meyer, N. [8 ]
Grange, F. [9 ]
Piulats, J. M. [10 ]
Bauman, J. [11 ]
Chirovsky, D. [12 ]
Zhang, P. [12 ]
Gumuscu, B. [12 ]
Swaby, R. [12 ]
Grob, J. J. [13 ]
机构
[1] Royal Brisbane & Womens Hosp, Herston, Qld, Australia
[2] Univ Queensland, Brisbane, Qld, Australia
[3] Ctr Estatal Cancerol Chihuahua, El Bajo, Chihuahua, Mexico
[4] Hop St Louis, Paris, France
[5] Rambam Hlth Care Campus, Haifa, Israel
[6] Sheba Med Ctr, Ramat Gan, Israel
[7] Townsville Canc Ctr, Townsville, Qld, Australia
[8] IUCT Oncopole, Toulouse, France
[9] Hop Robert Debre, CHU Reims, Reims, France
[10] Hosp Duran & Reinals ICO Hospitalet, Barcelona, Spain
[11] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[12] Merck & Co Inc, Kenilworth, NJ USA
[13] AIX Marseille Univ, Marseille, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
119
引用
收藏
页码:1131 / 1132
页数:2
相关论文
共 50 条
  • [1] Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629
    Hughes, Brett G. M.
    Gonzalez Mendoza, Rene
    Basset-Seguin, Nicole
    Vornicova, Olga
    Schachter, Jacob
    Joshi, Abhishek
    Meyer, Nicolas
    Grange, Florent
    Piulats, Josep M.
    Bauman, Jessica R.
    Chirovsky, Diana
    Zhang, Pingye
    Gumuscu, Burak
    Swaby, Ramona F.
    Grob, Jean-Jacques
    DERMATOLOGY AND THERAPY, 2021, 11 (05) : 1777 - 1790
  • [2] Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629
    Brett G. M. Hughes
    Rene Gonzalez Mendoza
    Nicole Basset-Seguin
    Olga Vornicova
    Jacob Schachter
    Abhishek Joshi
    Nicolas Meyer
    Florent Grange
    Josep M. Piulats
    Jessica R. Bauman
    Diana Chirovsky
    Pingye Zhang
    Burak Gumuscu
    Ramona F. Swaby
    Jean-Jacques Grob
    Dermatology and Therapy, 2021, 11 : 1777 - 1790
  • [3] Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629
    Åse Bratland
    Eva Munoz-Couselo
    Laurent Mortier
    Osama Roshdy
    Rene González
    Jacob Schachter
    Ana M. Arance
    Florent Grange
    Nicolas Meyer
    Abhishek Jagdish Joshi
    Salem Billan
    Brett G. M. Hughes
    Jean-Jacques Grob
    Karthik Ramakrishnan
    Joy Ge
    Burak Gumuscu
    Ramona F. Swaby
    Ralf Gutzmer
    Dermatology and Therapy, 2023, 13 : 3165 - 3180
  • [4] Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629
    Bratland, Ase
    Munoz-Couselo, Eva
    Mortier, Laurent
    Roshdy, Osama
    Gonzalez, Rene
    Schachter, Jacob
    Arance, Ana M.
    Grange, Florent
    Meyer, Nicolas
    Joshi, Abhishek Jagdish
    Billan, Salem
    Hughes, Brett G. M.
    Grob, Jean-Jacques
    Ramakrishnan, Karthik
    Ge, Joy
    Gumuscu, Burak
    Swaby, Ramona F.
    Gutzmer, Ralf
    DERMATOLOGY AND THERAPY, 2023, 13 (12) : 3165 - 3180
  • [5] Pembrolizumab in patients with recurrent or metastatic cutaneous squamous cell carcinoma (cSCC): The phase II KEYNOTE-629 study
    Licitra, L. F.
    Siu, L. L.
    Cohen, E. E. W.
    Zhang, P.
    Gumuscu, B.
    Swaby, R.
    Harrington, K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [6] KEYNOTE-629: Health-related quality of life (HRQoL) with pembrolizumab (pembro) in patients (pts) with locally advanced (LA) or recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC).
    Bratland, Ase
    Munoz-Couselo, Eva
    Mortier, Laurent
    Roshdy, Osama
    Gonzalez, Rene
    Schachter, Jacob
    Arance, Ana Maria
    Grange, Florent
    Meyer, Nicolas
    Joshi, Abhishek Jagdish
    Billan, Salem
    Hughes, Brett Gordon Maxwell
    Grob, Jean-Jacques
    Ramakrishnan, Karthik
    Zhang, Eric
    Gumuscu, Burak
    Swaby, Ramona F.
    Gutzmer, Ralf
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] KEYNOTE-629: Phase 2 trial of pembrolizumab in patients (pts) with recurrent or metastatic cutaneous squamous cell carcinoma (cSCC)
    Licitra, L.
    Siu, L.
    Cohen, E.
    Zhang, P.
    Gumuscu, B.
    Swaby, R.
    Harrington, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [8] KEYNOTE-629: Phase II study of pembrolizumab for recurrent/metastatic or locally advanced unresectable cutaneous squamous cell carcinoma
    Grob, Jean-Jacques
    Gonzalez Mendoza, Rene
    Basset-Seguin, Nicole
    Schachter, Jacob
    Vornicova, Olga
    Bauman, Jessica
    Grange, Florent
    Meyer, Nicolas
    Piulats, Josep
    Zhang, Pingye
    Gumuscu, Burak
    Swaby, Ramona
    Hughes, Brett G. M.
    CANCER RESEARCH, 2019, 79 (13)
  • [9] KEYNOTE-629: Phase 2 study of pembrolizumab for recurrent/metastatic or locally advanced unresectable cutaneous squamous cell carcinoma (cSCC).
    Grob, Jean Jacques
    Gonzalez, Rene
    Basset-Seguin, Nicole
    Schachter, Jacob
    Vornicova, Olga
    Bauman, Jessica Ruth
    Grange, Florent
    Meyer, Nicolas
    Piulats, Josep M.
    Zhang, Eric
    Gumuscu, Burak
    Swaby, Ramona F.
    Hughes, Brett Gordon Maxwell
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)
    Grob, Jean-Jacques
    Gonzalez, Rene
    Basset-Seguin, Nicole
    Vornicova, Olga
    Schachter, Jacob
    Joshi, Abhishek
    Meyer, Nicolas
    Grange, Florent
    Piulats, Josep M.
    Bauman, Jessica R.
    Zhang, Pingye
    Gumuscu, Burak
    Swaby, Ramona F.
    Hughes, Brett G. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (25) : 2916 - +